NuroBalance Forte

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Eleutherococcus senticosus, Quantity: 133.33 mg (Equivalent: Eleutherococcus senticosus, Qty 2 g; Equivalent: syringaresinol diglucosides (of Eleutherococcus senticosus), Qty 1.06 mg); Hypericum perforatum, Quantity: 450 mg (Equivalent: Hypericum perforatum, Qty 2.7 g; Equivalent: hyperforin (of Hypericum perforatum), Qty 13.5 mg; Equivalent: hypericins calculated as hypericin (of Hypericum perforatum), Qty 1.485 mg); zinc amino acid chelate, Quantity: 62.5 mg (Equivalent: zinc, Qty 12.5 mg); inositol, Quantity: 300 mg; Albizia julibrissin, Quantity: 75 mg (Equivalent: Albizia julibrissin, Qty 1.5 g); Crocus sativus, Quantity: 12.6 mg (Equivalent: Crocus sativus, Qty 42 mg)

Available from:

FIT-BioCeuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: maltodextrin; hypromellose; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; macrogol 8000; chlorophyllin-copper complex; Carnauba Wax; dextrin

Administration route:

Oral

Therapeutic indications:

Traditionally used in Western herbal medicine to Relieve weariness/tiredness/fatigue/feeling of weakness ; Traditionally used in Western herbal medicine to Adaptogen/Help body adapt to stress ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve symptoms of mild anxiety ; Maintain/support cognitive function/mental function ; Maintain/support nerve conduction ; Maintain/support nervous system function ; Support healthy emotional/mood balance ; Traditionally used in Western herbal medicine to Support healthy emotional/mood balance ; Traditionally used in Persian/Iranian medicine to Support healthy emotional/mood balance

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2018-07-30